Clinical trial
Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes…
NCT00361881 · Medivir, Industry · Completed
Key facts
| NCT number | NCT00361881 |
|---|---|
| Title | Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis |
| Official title | A Randomized, Double-Blind, Active Controlled, Vehicle-Controlled, Subject Initiated Study Comparing Efficacy and Safety of ME-609 Versus Acyclovir Cream for Treatment of Recurrent Herpes Simplex Labialis |
| Lead sponsor | Medivir, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Herpes Labialis |
| Intervention type | Drug |
| Interventions | ME-609, acyclovir in ME-609 vehicle, Vehicle |
| Enrollment | 1,443 |
| Start date | Jul 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Aug 9, 2006 |
| Last update posted | Aug 18, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: